ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "aa45c1ee-2e41-4cb9-86f5-fca15f3bf2e7"}, "_deposit": {"created_by": 3, "id": "12178", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "12178"}, "status": "published"}, "_oai": {"id": "oai:ir.kagoshima-u.ac.jp:00012178", "sets": ["65", "4795"]}, "author_link": ["5730", "78996", "78995"], "item_7_alternative_title_18": {"attribute_name": "別言語のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Local Anesthetics and Vasoconstrictors in Dentistry"}]}, "item_7_alternative_title_19": {"attribute_name": "タイトルよみ", "attribute_value_mlt": [{"subitem_alternative_title": "シカヨウ キョクショ マスイヤク ト ケッカン シュウシュクヤク"}]}, "item_7_biblio_info_5": {"attribute_name": "収録雑誌名", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1996", "bibliographicIssueDateType": "Issued"}, "bibliographicPageEnd": "11", "bibliographicPageStart": "1", "bibliographicVolumeNumber": "16", "bibliographic_titles": [{"bibliographic_title": "鹿児島大学歯学部紀要"}]}]}, "item_7_date_6": {"attribute_name": "作成日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "1996-03-25"}]}, "item_7_description_4": {"attribute_name": "要約(Abstract)", "attribute_value_mlt": [{"subitem_description": "Vasoconstrictors, such as epinephrine and norepinephrine, are commonly contained in local anesthetics to decrease systemic toxicity and prolong the duration of action by retarding anesthetic absorption. These catecholamines have varying degrees of α and β adrenergic effects, resulting in cardiac and hemodynamic changes. On the other hand, several investigators have reported that clinical doses of these drugs have little effects on cardiovascular system, as far as they are evaluated with such conventional parameters as heart rate and blood pressure. Thus, the problems about the permissible doses of catecholamines contained in local anesthetics in dentistry have been still in controversy. In recent years, however, detailed studies have clarified that catecholamines, even if in clinical doses, cause marked circulatory changes beyond expectation. Our date using echocardiography dernonstrated that 45 μg of epinephrine contained in lidocaine caused significant increases in heart rate and stroke volume with a resultant increase in cardiac output. Tachycardia was due to the action of epinephrine on β_1 receptors of the pacemaker cells. The increase in stroke volume was caused by an augmentation of myocardial contractility and a decrease in afterload. Mean blood pressure was relatively stabilized because of a reduction in total peripheral resistance in spite of the increase in cardiac output. In contrast to epinephrine, more than 72 μg of norepinephrine contained in lidocaine produced a remarkable increase in total peripheral resistance and corresponding elevation in mean blood pressure. The reason for this was that norepinephrine stimulated α_1 receptors of vessels in skeletal muscle, thus leading to vasoconstriction. The elevation in mean blood pressure brought about the negative chronotropic and inotropic changes of the heart through the baroreceptor reflex. Felypressin, non-adrenergic vasoconstrictor, has been believed to have no direct effects on the heart, although it is less effective than epinephrine in prevention of bleeding and anesthetic potency. For that reason, anesthetics containing felypressin are usually used by choice in dental patients with cardiovascular disease. However, a large dose of felypressin has been reported to constrict coronary artery. Recent investigations indicate that felypressin has distinct effects on circulation and a depressant effect on cardiac function in ischemic heart. Consequently, the doses of epinephrine and norepinephrine contained in local anesthetics should be less than 45 and 72 μg, respectively. In cardiac patients, the administration of low concentration of epinephrine might be necessary according to the degree of severity of the disease.", "subitem_description_type": "Other"}]}, "item_7_full_name_2": {"attribute_name": "著者よみ", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "78995", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "スギヤマ, カズナ"}]}]}, "item_7_full_name_3": {"attribute_name": "別言語の著者", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "78996", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Sugiyama, Kazuna"}]}]}, "item_7_publisher_23": {"attribute_name": "公開者・出版者", "attribute_value_mlt": [{"subitem_publisher": "鹿児島大学"}]}, "item_7_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0389-7834", "subitem_source_identifier_type": "ISSN"}]}, "item_7_source_id_9": {"attribute_name": "NII書誌ID", "attribute_value_mlt": [{"subitem_source_identifier": "AN0035442X", "subitem_source_identifier_type": "NCID"}]}, "item_7_subject_15": {"attribute_name": "NDC", "attribute_value_mlt": [{"subitem_subject": "497", "subitem_subject_scheme": "NDC"}]}, "item_7_subject_20": {"attribute_name": "NIIsubject", "attribute_value_mlt": [{"subitem_subject": "歯学", "subitem_subject_scheme": "Other"}]}, "item_7_text_24": {"attribute_name": "公開者よみ", "attribute_value_mlt": [{"subitem_text_value": "カゴシマ ダイガク"}]}, "item_7_text_25": {"attribute_name": "公開者別名", "attribute_value_mlt": [{"subitem_text_value": "Kagoshima University"}]}, "item_7_text_30": {"attribute_name": "NIIタイプ", "attribute_value_mlt": [{"subitem_text_value": "Departmental Bulletin Paper"}]}, "item_7_version_type_14": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "椙山, 加綱"}], "nameIdentifiers": [{"nameIdentifier": "5730", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "1000050124772", "nameIdentifierScheme": "NRID", "nameIdentifierURI": " "}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2016-10-31"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00000165796.pdf", "filesize": [{"value": "1.0 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1000000.0, "url": {"label": "KJ00000165796.pdf", "url": "https://ir.kagoshima-u.ac.jp/record/12178/files/KJ00000165796.pdf"}, "version_id": "0f44dc2b-a994-428e-9b50-e26dcc994e71"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Epinephrine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Norepinephrine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Felypressin", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Circulation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Cardiovascular disease", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "歯科用局所麻酔薬と血管収縮薬", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "歯科用局所麻酔薬と血管収縮薬"}]}, "item_type_id": "7", "owner": "3", "path": ["65", "4795"], "permalink_uri": "http://hdl.handle.net/10232/356", "pubdate": {"attribute_name": "公開日", "attribute_value": "2015-04-28"}, "publish_date": "2015-04-28", "publish_status": "0", "recid": "12178", "relation": {}, "relation_version_is_last": true, "title": ["歯科用局所麻酔薬と血管収縮薬"], "weko_shared_id": 3}
  1. 掲載誌一覧
  2. 鹿児島大学歯学部紀要
  3. vol. 16
  1. 歯学部
  2. 歯学部・紀要論文

歯科用局所麻酔薬と血管収縮薬

http://hdl.handle.net/10232/356
http://hdl.handle.net/10232/356
3156dc61-7ccf-4c9c-a2ed-4c11a57ef368
名前 / ファイル ライセンス アクション
KJ00000165796.pdf KJ00000165796.pdf (1.0 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2015-04-28
タイトル
タイトル 歯科用局所麻酔薬と血管収縮薬
タイトルよみ
タイトルよみ シカヨウ キョクショ マスイヤク ト ケッカン シュウシュクヤク
別言語のタイトル
その他のタイトル Local Anesthetics and Vasoconstrictors in Dentistry
著者 椙山, 加綱

× 椙山, 加綱

WEKO 5730
NRID 1000050124772

椙山, 加綱

Search repository
著者よみ
姓名 スギヤマ, カズナ
別言語の著者
姓名 Sugiyama, Kazuna
言語
言語 jpn
キーワード
主題Scheme Other
主題 Epinephrine
キーワード
主題Scheme Other
主題 Norepinephrine
キーワード
主題Scheme Other
主題 Felypressin
キーワード
主題Scheme Other
主題 Circulation
キーワード
主題Scheme Other
主題 Cardiovascular disease
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ departmental bulletin paper
要約(Abstract)
内容記述タイプ Other
内容記述 Vasoconstrictors, such as epinephrine and norepinephrine, are commonly contained in local anesthetics to decrease systemic toxicity and prolong the duration of action by retarding anesthetic absorption. These catecholamines have varying degrees of α and β adrenergic effects, resulting in cardiac and hemodynamic changes. On the other hand, several investigators have reported that clinical doses of these drugs have little effects on cardiovascular system, as far as they are evaluated with such conventional parameters as heart rate and blood pressure. Thus, the problems about the permissible doses of catecholamines contained in local anesthetics in dentistry have been still in controversy. In recent years, however, detailed studies have clarified that catecholamines, even if in clinical doses, cause marked circulatory changes beyond expectation. Our date using echocardiography dernonstrated that 45 μg of epinephrine contained in lidocaine caused significant increases in heart rate and stroke volume with a resultant increase in cardiac output. Tachycardia was due to the action of epinephrine on β_1 receptors of the pacemaker cells. The increase in stroke volume was caused by an augmentation of myocardial contractility and a decrease in afterload. Mean blood pressure was relatively stabilized because of a reduction in total peripheral resistance in spite of the increase in cardiac output. In contrast to epinephrine, more than 72 μg of norepinephrine contained in lidocaine produced a remarkable increase in total peripheral resistance and corresponding elevation in mean blood pressure. The reason for this was that norepinephrine stimulated α_1 receptors of vessels in skeletal muscle, thus leading to vasoconstriction. The elevation in mean blood pressure brought about the negative chronotropic and inotropic changes of the heart through the baroreceptor reflex. Felypressin, non-adrenergic vasoconstrictor, has been believed to have no direct effects on the heart, although it is less effective than epinephrine in prevention of bleeding and anesthetic potency. For that reason, anesthetics containing felypressin are usually used by choice in dental patients with cardiovascular disease. However, a large dose of felypressin has been reported to constrict coronary artery. Recent investigations indicate that felypressin has distinct effects on circulation and a depressant effect on cardiac function in ischemic heart. Consequently, the doses of epinephrine and norepinephrine contained in local anesthetics should be less than 45 and 72 μg, respectively. In cardiac patients, the administration of low concentration of epinephrine might be necessary according to the degree of severity of the disease.
収録雑誌名 鹿児島大学歯学部紀要

巻 16, p. 1-11, 発行日 1996
作成日
日付 1996-03-25
ISSN
収録物識別子タイプ ISSN
ISSN 0389-7834
NII書誌ID(雑誌)
収録物識別子タイプ NCID
NC ID AN0035442X
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
NDC
主題Scheme NDC
主題 497
NIIsubject
主題Scheme Other
主題 歯学
公開者・出版者
出版者 鹿児島大学
公開者よみ
公開者よみ カゴシマ ダイガク
公開者別名
公開者別名 Kagoshima University
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-25 14:07:53.841509
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3